Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients.
Abdelaty, Lamiaa N
Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients. [electronic resource] - Current drug safety 2020 - 53-60 p. digital
Publication Type: Journal Article
2212-3911
10.2174/1574886314666191001151314 doi
Adult
Aged
Antiviral Agents--administration & dosage
Benzimidazoles--therapeutic use
Carbamates
Drug Therapy, Combination
Drug-Related Side Effects and Adverse Reactions
Egypt
Female
Fluorenes--therapeutic use
Genotype
Hepatitis C, Chronic--blood
Humans
Imidazoles--therapeutic use
Liver Cirrhosis
Male
Middle Aged
Pyrrolidines
Random Allocation
Sofosbuvir--therapeutic use
Treatment Outcome
Valine--analogs & derivatives
Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients. [electronic resource] - Current drug safety 2020 - 53-60 p. digital
Publication Type: Journal Article
2212-3911
10.2174/1574886314666191001151314 doi
Adult
Aged
Antiviral Agents--administration & dosage
Benzimidazoles--therapeutic use
Carbamates
Drug Therapy, Combination
Drug-Related Side Effects and Adverse Reactions
Egypt
Female
Fluorenes--therapeutic use
Genotype
Hepatitis C, Chronic--blood
Humans
Imidazoles--therapeutic use
Liver Cirrhosis
Male
Middle Aged
Pyrrolidines
Random Allocation
Sofosbuvir--therapeutic use
Treatment Outcome
Valine--analogs & derivatives